Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients by Alexander A. Berezin, Ivan M. Fushtey, Alexander E. Berezin

Get full text

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure by Alexander A. Berezin, Ivan M. Fushtey, Alexander E. Berezin

Get full text

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus by Alexander A. Berezin, Ivan M. Fushtey, Sergii V. Pavlov, Alexander E. Berezin

Get full text

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus by Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Ivan M. Fushtey, Alexander E. Berezin

Get full text

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure by Alexander A. Berezin, Anica Babic Obradovic, Ivan M. Fushtey, Tetiana A Berezina, Michael Lichtenauer, Alexander E Berezin

Get full text

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure by Alexander A. Berezin, Zeljko Obradovic, Ivan M. Fushtey, Tetiana A. Berezina, Evgen V. Novikov, Lukas Schmidbauer, Michael Lichtenauer, Alexander E. Berezin

Get full text